Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression

Molecular Genetics and Metabolism

Volumn 78, Issue 3, 2003, Pages 175-185

  Verrijdt, Guy ^a   Haelens, Annemie ^a   Claessens, Frank ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; DNA; GLUCOCORTICOID; MINERALOCORTICOID; PROGESTERONE; SECRETORY COMPONENT;

ALPHA HELIX; ARTICLE; DIMERIZATION; DNA BINDING; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; ENHANCER REGION; GENE EXPRESSION REGULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; TRANSCRIPTION REGULATION;

EID: 0037340162     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00003-9     Document Type: Article

References (93)

1. Miesfeld R., Okret S., Wikstrom A.C., Wrange O., Gustafsson J.-Å., Yamamoto K.R. Characterisation of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature. 312:1984;779-781.
2. Misrahi M., Atger M., d'Auriol L., Loosfelt H., Meriel C., Fridlansky F., Guiochon-Mantel A., Galibert F., Milgrom E. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem. Biophys. Res. Commun. 143:1987;740-748.
3. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 320:1986;134-139.
4. Green S., Walter P., Greene G., Krust A., Goffin C., Jensen E., Scrace G., Waterfield M., Chambon P. Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 24:1986;77-83.
5. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 237:1987;268-275.
6. Trapman J., Klaassen P., Kuiper G.G., van der Korput J.A., Faber P.W., van Rooij H.C., Geurts van Kessel A., Voorhorst M.M., Mulder E., Brinkmann A.O. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem. Biophys. Res. Commun. 153:1988;241-248.
7. Lubahn D.B., Joseph D.R., Sullivan P.M., Willard H.F., French F.S., Wilson E.M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science. 240:1988;327-330.
8. Chang C.S., Kokontis J., Liao S.T. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science. 240:1988;324-326.
9. Tilley W.D., Marcelli M., Wilson J.D., McPhaul M.J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA. 86:1989;327-331.
10. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-894.
11. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
12. Whithfield G.K., Jurutka P.W., Haussler C.A., Haussler M.R. Steroid hormone receptors: evolution, ligands and molecular basis of biologic function. J. Cell Biochem. Suppl. 32/33:1999;110-122.
13. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
14. Cato A.C.B., Ponta H., Herrlich P. Regulation of gene expression by steroid hormones. Prog. Nucl. Acid Res. Mol. Biol. 43:1992;1-37.
15. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15:1994;391-407.
16. Parker M.G. Steroid and related receptors. Curr. Opin. Cell Biol. 5:1993;499-504.
17. Zhao Q., Khorasanizadeh S., Myoshi Y., Lazar M.A., Rastinejad F. Structural elements of an orphan nuclear receptor-DNA complex. Mol. Cell. 1:1998;849-861.
18. Meinke G., Sigler P.B. DNA-binding mechanism of the monomeric orphan receptor NGFI-B. Nat. Struct. Biol. 6:1999;471-477.
19. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
20. Tsai M., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
21. Renaud J.P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
22. Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1356.
23. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160. kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors EMBO J. 15:1996;3667-3675.
24. Heery D.M., Kalkoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
25. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.-M., Krones A., Inostroza J., Torchia J., Nolte R.T., Assa-Munt N., Milburn M.V., Glass C.K., Rosenfeld M.G. Determinants of coactivator LxxLL motif specificity in nuclear receptor transcriptional activation. Genes & Development. 12:1998;3357-3368.
26. Poujol N., Wurtz J.-M., Tahiri B., Lumbroso S., Nicolas J.-C., Moras D., Sultan C. Specific recognition of androgens by their nuclear receptor. A structure-function study. J. Biol. Chem. 275:2000;24022-24031.
27. Matias P.M., Donner P., Coelho R., Thomaz M., Peixoto C., Macedo S., Otto N., Joschko S., Scholz P., Wegg A., Bäsler S., Schäffer M., Egner U., Carrondo M.A. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J. Biol. Chem. 275:2000;26164-26171.
28. Buchanan G., Yang M., Harris J.M., Nahm H.S., Han G., Moore N., Bentel J.M., Matusik R.J., Horsfall D.J., Marshall V.R., Greenberg N.M., Tilley W.D. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Mol. Endocrinol. 15:2001;46-56.
29. Berrevoets C.A., Doesburg P., Steketee K., Trapman J., Brinkmann A.O. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2). Mol. Endocrinol. 12:1998;1172-1183.
30. Wang Q., Lu J., Yong E.L. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. J. Biol. Chem. 276:2001;7493-7499.
31. Jenster G., van der Korput H.A.G.M., Trapman J., Brinkmann A.O. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J. Biol. Chem. 270:1995;7341-7346.
32. Chamberlain N.L., Whitacre D.C., Miesfeld R.L. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J. Biol. Chem. 271:1996;26772-26778.
33. Bevan C., Parker M. The role of coactivators in steroid hormone action. Exp. Cell Res. 253:1999;349-356.
34. Alen P., Claessens F., Verhoeven G., Rombauts W., Peeters B. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell Biol. 19:1999;6085-6097.
35. Bevan C.L., Hoare S., Claessens F., Heery D.M., Parker M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol. Cell Biol. 19:1999;8383-8392.
36. Christiaens V., Bevan C., Callewaert L., Haelens A., Verrijdt G., Rombauts W., Claessens F. Characterization of the two interacting surfaces of the androgen receptor and their relative role in transcriptional control. J. Biol. Chem. 277:2002;49230-49237.
37. Doesburg P., Kuil C.W., Berrevoets C.A., Steketee K., Faber P.W., Mulder E., Brinkmann A.O., Trapman J. Functional in vivo interaction between the amino-terminal transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry. 36:1997;1052-1064.
38. L. Callewaert, G. Verrijdt, V. Christiaens, A. Haelens, F. Claessens, Dual function of an amino-terminal amphipatic helix in androgen-receptor-mediated transactivation through specific and non-specific response elements, J. Biol. Chem. e-pub ahead of print, published December 31, 2002 as 10.1074/jbc.M210744200.
39. He B., Kemppainen J.A., Wilson E.M. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding of the androgen receptor. J. Biol. Chem. 275:2000;22986-22994.
40. Funder J.W. Mineralocorticoids, glucocorticoids, receptors and response elements. Science. 259:1993;1132-1133.
41. Ning Y.-M., Robins D.M. AML3/CBFα1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (slp) gene. J. Biol. Chem. 274:1999;30624-30630.
42. Müller J.M., Isele U., Metzger E., Rempel A., Moser M., Pscherer A., Breyer T., Holubarsch C., Buettner R., Schüle R. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:2000;359-369.
43. Umesono K., Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell. 57:1989;1139-1146.
44. Schwabe J.W.R., Chapman L., Finch J.T., Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 75:1993;567-578.
45. Tsai S.Y., Carlstedt-Duke J., Weigel N.L., Dahlman K., Gustafsson J.-Å., Tsai M.J., O'Malley B.W. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell. 55:1988;361-369.
46. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
47. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 375:1995;203-211.
48. Rastinejad F., Wagner T., Zhao Q., Khorasanizadeh S. Structure of the RXR-RAR DNA-binding complex on the retinoid acid response element DR1. EMBO J. 19:2000;1045-1054.
49. Zechel C., Shen X.Q., Chen J.Y., Chen Z.P., Chambon P., Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13:1994;1425-1433.
50. Shaffer P.L., Gewirth D.T. Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J. 21:2002;2242-2252.
51. Rennie P.S., Bruchovsky N., Leco K.J., Sheppard P.C., McQueen S.A., Cheng H., Snoek R., Hamel A., Bock M.E., MacDonald B.S., Nickel B.E., Chang C., Liao S., Cattini P.A., Matusik R.J. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol. 7:1993;23-36.
52. Claessens F., Alen P., Devos A., Peeters B., Verhoeven G., Rombauts W. The androgen-specific probasin response element interacts differentially with androgen and glucocorticoid receptors. J. Biol. Chem. 271:1996;19013-19016.
53. Schoenmakers E., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J. Biol. Chem. 275:2000;12290-12297.
54. Rundlett S.E., Miesfeld R.L. Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation. Mol. Cell Endocrinol. 109:1995;1-10.
55. Kasper S., Rennie P.S., Bruchovsky N., Lin L., Cheng H., Snoek R., Dahlman-Wright K., Gustafsson J.-Å., Shiu R.P.C., Sheppard P.C., Matusik R.J. Selective activation of the probasin androgen-responsive region by steroid hormones. J. Mol. Endocrinol. 22:1999;313-325.
56. Whitacre D.C., Karnas K.J., Miesfeld R.L. Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity. Endocrine. 15:2001;111-118.
57. Zilliacus J., Wright A.P.H., Carlstedt-Duke J., Gustafsson J.-Å. Structural determinants of DNA-binding specificity by steroid receptors. Mol. Endocrinol. 9:1995;389-400.
58. Truss M., Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Reviews. 14:1993;459-479.
59. Zilliacus J., Wright A.P.H., Norinder U., Gustafsson J.-Å., Carlstedt-Duke J. Determinants for DNA-bindng site recognition by the glucocorticoid receptor. J. Biol. Chem. 267:1992;24941-24947.
60. Kasper S., Rennie P.S., Bruchovsky N., Sheppard P.C., Cheng H., Lin L., Shiu R.P.C., Snoek R., Matusik R.J. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J. Biol. Chem. 269:1994;31763-31769.
61. Verrijdt G., Schoenmakers E., Alen P., Haelens A., Peeters B., Rombauts W., Claessens F. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol. Endocrinol. 13:1999;1558-1570.
62. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., Claessens F. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J. Biol. Chem. 275:2000;12298-12305.
63. Loreni F., Stavenhagen J., Kalff M., Robins D.M. A complex androgen-responsive enhancer resides 2. kb upstream of the mouse slp gene Mol. Cell Biol. 8:1988;2350-2360.
64. Scheller A., Hughes E., Golden K.L., Robins D.M. Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation. J. Biol. Chem. 273:1998;24216-24222.
65. Verrijdt G., Schauwaers K., Haelens A., Claessens F. Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer. J. Biol. Chem. 277:2002;35191-35201.
66. Adler A.J., Scheller A., Hoffman Y., Robins D.M. Multiple components of a complex androgen-dependent enhancer. Mol. Endocrinol. 5:1991;1587-1596.
67. Schoenmakers E., Alen A., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem. J. 341:1999;515-521.
68. Verrijdt G., Haelens A., Schoenmakers E., Rombauts W., Claessens F. Comparative analysis of the influence of the high-mobiblity group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem. J. 361:2002;97-103.
69. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., Taraseviciene L., Nordeen S.K., Allegretto E.A., Edwards D.P. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell Biol. 18:1998;4471-4487.
70. Melvin V.S., Edwards D.P. Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and 2. Steroids. 64:1999;576-586.
71. Melvin V.S., Roemer S.C., Churchill M.E.A., Edwards D.P. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J. Biol. Chem. 277:2002;25115-25124.
72. Roche P.J., Hoare S.A., Parker M.G. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6:1992;2229-2235.
73. Nelson C.C., Hendy S.C., Shukin R.J., Cheng H., Bruchowsky N., Koop B.F., Rennie P.S. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol. Endocrinol. 13:1999;2090-2107.
74. Haelens A., Verrijdt G., Callewaert L., Peeters B., Rombauts W., Claessens F. Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene. Biochem. J. 353:2001;611-620.
75. Payvar F., DeFranco D., Firestone G.L., Edgar B., Wrange O., Okret S., Gustafsson J.-Å., Yamamoto K.R. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell. 35:1983;381-392.
76. Khorasanizadeh S., Rastinejad F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26:2001;384-390.
77. Préfontaine G.G., Walther R., Giffin W., Lemieux M.E., Pope L., Haché R.J.G. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. J. Biol. Chem. 274:1999;26713-26719.
78. Celis L., Claessens F., Peeters B., Heyns W., Verhoeven G., Rombauts W. Proteins interacting with an androgen-responsive unit in the C3(1) gene intron. Mol. Cell Endocrinol. 94:1993;165-172.
79. Claessens F., Celis L., Heyns W., Verhoeven G., Rombauts W. Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem. Biophys. Res. Comm. 164:1989;833-840.
80. Shan J.-D., Porvari K., Ruokonen M., Karhu A., Launonen V., Hedberg P., Oikarinen J., Vihko Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen and prostate-specific glandular kallikrein. Endocrinology. 138:1997;3764-3770.
81. Huang W., Shostak Y., Tarr P., Sawyers C., Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274:1999;25756-25768.
82. Grad J.M., Lyons L.S., Robins D.M., Burnstein K.L. The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of the AR gene expression via an exonic enhancer. Endocrinology. 142:2001;1107-1116.
83. Gonzalez M.I., Robins D.M. Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1. J. Biol. Chem. 276:2001;6420-6428.
84. Haelens A., Verrijdt G., Schoenmakers E., Alen P., Peeters B., Rombauts W., Claessens F. The first exon of the human sc gene contains an androgen responsive unit and an interferon regulatory factor element. Mol. Cell Endocrinol. 153:1999;91-102.
85. Barbulescu K., Geserick C., Schuttke I., Schleuning W.D., Haendler B. New androgen response elements in the murine pem promoter mediate selective transactivation. Mol. Endocrinol. 15:2001;1803-1816.
86. Haelens A., Verrijdt G., Callewaert L., Christiaens V., Schauwaers K., Peeters B., Rombauts W., Claessens F. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization and an active role of sequences flanking the response element on transactivation. Biochem. J. 369:2003;141-151.
87. Ho K.-C., Marschke K.B., Tan J., Power S.G.A., Wilson E.M., French F.S. A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. J. Biol. Chem. 268:1993;27226-27235.
88. Darne C.H., Morel L., Claessens F., Manin M., Fabre S., Veyssiere G., Rombauts W., Jean C.L. Ubiquitous transcription factors NF-I and Sp1 are involved in the androgen activation of the mouse vas deferens protein promoter. Mol. Cell Endocrinol. 132:1997;13-23.
89. Ham J., Thomson A., Needham M., Webb P., Parker M.G. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucl. Acids Res. 16:1988;5263-5276.
90. Lund S.D., Gallagher P.M., Wang B., Porter S.C., Ganschow R.E. Androgen responsiveness of the murine β-glucuronidase gene is associated with nuclease hypersensitivity, protein binding and haplotype-specific sequence diversity within intron 9. Mol. Cell Biol. 11:1991;5426-5434.
91. Lu S., Liu M., Epner D.E., Tsai S.Y., Tsai M.-J. Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol. Endocrinol. 13:1999;376-384.
92. ′ promoter region of the gene Biochemistry. 32:1993;6459-6464.
93. Yu D.-C., Sakamoto G.T., Henderson D.R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59:1999;1498-1504.